paroxetine has been researched along with Breast Cancer in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 16 (51.61) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bannink, M; Binkhorst, L; Jager, A; Mathijssen, RH; van Gelder, T; van Herk-Sukel, MP; Wiemer, EA | 1 |
| Kaplan, M; Mahon, SM | 1 |
| Boudreau, DM; Bowles, EJ; Buist, DS; Chubak, J; Fujii, M; Yu, O | 1 |
| Ahmed, SA; Avila, C; Cheetham, TC; Chung, J; Fletcher, SW; Habel, LA; Haque, R; Kleinman, K; Kwan, ML; Schottinger, JE; Shi, J | 1 |
| Baker, H | 1 |
| Ahlgren, J; Fredriksson, I; Garmo, H; Holmberg, L; Sund, M; Valachis, A; Weinman, J | 1 |
| Andersohn, F; Willich, SN | 1 |
| Austin, PC; Duong-Hua, M; Gomes, T; Juurlink, DN; Kelly, CM; Paszat, LF; Pritchard, KI | 1 |
| Jenkinson, ML | 1 |
| Dobzhenko, MN; Shchepotin, IB; Zotov, AS | 1 |
| Kiyotani, K; Mushiroda, T; Nakamura, Y; Sasa, M; Zembutsu, H | 1 |
| Appiani, F; Carroll, BT; Muñoz, C; Trecco, J | 1 |
| Andrade, C | 1 |
| Goetz, MP; Loprinzi, CL | 1 |
| Bhargava, P; Desta, Z; Flockhart, DA; Hayes, DF; Johnson, MD; Morocho, A; Novielli, A; Rae, JM; Stearns, V | 1 |
| Stearns, V | 1 |
| Biglia, N; Ponzone, R; Sismondi, P | 1 |
| Bushunow, P; Griggs, JJ; Hickok, JT; Matteson, SE; Morrow, GR; Mustian, KM; Qazi, R; Roscoe, JA; Smith, B | 1 |
| Chen, W; Enger, SM; Haque, R; Petitti, DB | 1 |
| Adelson, KB; Hershman, DL; Loprinzi, CL | 1 |
| Bunnell, C; Cullen, J; Gallagher, A; Gehan, E; Greep, N; Hayes, DF; Henry-Tilman, R; Isaacs, C; Osborne, M; Slack, R; Stearns, V; Ullmer, L | 1 |
| Baber, R; Hickey, M; Kwik, M | 1 |
| Evans, DL; Goodkin, R; Guo, Y; Lawson, D; Lawson, K; Lewison, B; Manatunga, AK; Musselman, DL; Nemeroff, CB; Penna, S; Porter, M; Somerset, WI | 1 |
| Krajnik, M; Zylicz, Z | 1 |
| Crawford, J; Ellis, MJ; Hanfelt, JJ; Hayes, DF; Isaacs, C; Kramer, R; Lawrence, W; Rowland, J; Stearns, V | 1 |
| Contu, A; Gutschow, K; Möslinger-Gehmayr, R; Oberhoff, C; Schindler, AE; Staab, HJ; Zaninelli, R | 1 |
| Cotterchio, M; Darlington, G; Kreiger, N; Steingart, A | 1 |
| Contu, A; Moslinger-Gehmayr, R; Pezzella, G | 1 |
| Jacobsen, PB; Minton, S; Moncello, J; Weitzner, MA | 1 |
8 review(s) available for paroxetine and Breast Cancer
| Article | Year |
|---|---|
[Selective serotonin reuptake inhibitors and mammary pathologies].
Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Paroxetine; Polymorphism, Genetic; Receptors, Estrogen; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome | 2011 |
A hot flash on tamoxifen metabolism.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride | 2003 |
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Treatment of hot flushes in breast and prostate cancer.
Topics: Amines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cimicifuga; Contraindications; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroacupuncture; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hormone Replacement Therapy; Hot Flashes; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Paroxetine; Phytotherapy; Plant Preparations; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2005 |
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2005 |
The management of chronic pain in patients with breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Society of Palliative Care Physicians. Canadian Association of Radiation Oncologist
Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Breast Neoplasms; Chronic Disease; Female; Humans; Morphine; Pain; Pain Measurement; Paroxetine; Professional Staff Committees; Severity of Illness Index | 1998 |
[Pruritus in cancer: uncommon, but sometimes worse than the pain].
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Bronchogenic; Cholestasis; Diagnosis, Differential; Fatal Outcome; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Paroxetine; Pruritus; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome; Tropisetron | 1999 |
8 trial(s) available for paroxetine and Breast Cancer
| Article | Year |
|---|---|
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Female; Humans; Microsomes, Liver; Middle Aged; Paroxetine; Prospective Studies; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome | 2003 |
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Breast Neoplasms; Depression; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Treatment Outcome | 2005 |
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Topics: Adult; Aged; Breast Neoplasms; Cross-Over Studies; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Patient Compliance; Placebos; Quality of Life; Selective Serotonin Reuptake Inhibitors | 2005 |
A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Breast; Breast Neoplasms; Comorbidity; Depressive Disorder, Major; Desipramine; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Staging; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2006 |
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Topics: Adult; Aged; Anxiety; Breast Neoplasms; Confidence Intervals; Depression; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Survivors | 2000 |
[A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Breast Neoplasms; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Personality Inventory; Sick Role | 2000 |
Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Breast Neoplasms; Depression; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome | 2001 |
A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Depression; Fatigue; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders | 2002 |
15 other study(ies) available for paroxetine and Breast Cancer
| Article | Year |
|---|---|
Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.
Topics: Antidepressive Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Prescriptions; Enzyme Inhibitors; Female; Fluoxetine; Humans; Netherlands; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2013 |
Paroxetine approval.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Antagonism; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2014 |
Breast cancer recurrence in relation to antidepressant use.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Breast Neoplasms; Depressive Disorder; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paroxetine; Risk; Young Adult | 2016 |
Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cohort Studies; Depression; Female; Health Resources; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Paroxetine; Proportional Hazards Models; Survivors; Tamoxifen; United States | 2016 |
Use of antidepressants and breast cancer recurrence.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Depression; Female; Humans; Neoplasm Recurrence, Local; Paroxetine; Tamoxifen | 2016 |
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Depression; Female; Humans; Ontario; Paroxetine; Patient Compliance; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome | 2016 |
Interaction of serotonin reuptake inhibitors with tamoxifen.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Depressive Disorder; Drug Interactions; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2010 |
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cohort Studies; Depressive Disorder; Drug Interactions; Female; Humans; Ontario; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2010 |
SSRIs and tamoxifen. Why condemn fluoxetine?
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2010 |
Tamoxifen-SSRIs interaction: clinical manifestations of inhibition and lack of inhibition of CYP2D6.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal; Citalopram; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Interactions; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2011 |
Breast cancer and antidepressant use.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Breast Neoplasms; Contraindications; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Drug Interactions; Female; Hot Flashes; Humans; Paroxetine; Prodrugs; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen | 2012 |
Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cytochrome P-450 CYP2D6 Inhibitors; Estrogen Receptor Modulators; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2004 |
Breast cancer risk in a large cohort of female antidepressant medication users.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Breast Neoplasms; Cohort Studies; Female; Humans; Middle Aged; Paroxetine; Retrospective Studies; Risk Factors; Time Factors | 2005 |
Antidepressant medication use and breast cancer risk.
Topics: Adult; Age Distribution; Aged; Antidepressive Agents; Breast Neoplasms; Case-Control Studies; Confounding Factors, Epidemiologic; Female; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Odds Ratio; Ontario; Paroxetine; Population Surveillance; Risk Factors; Selective Serotonin Reuptake Inhibitors; Socioeconomic Factors; Surveys and Questionnaires | 2000 |
Breast cancer and hot flashes. Options for relief.
Topics: Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |